GGrantIndex
Sort

53,477 grants matching addiction

NOVEL MEDICATION APPROACHES FOR SUBSTANCE ABUSE

$1,959,826
New York State Psychiatric Institute · P50 · FY2001 · DA

Clinical Trials Network: The Texas Node

$1,959,205
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2018 · DA

TOBACCO DEPENDENCE AND RISK FACTORS FOR TREATMENT FAILUR

$1,959,133
Yale University · P50 · FY2000 · DA

Center for Opioid and Cocaine Addiction (COCA)

$1,958,577
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2020 · DA

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

$1,958,246
Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2014 · DA

Center for Opioid and Cocaine Addiction (COCA)

$1,956,891
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2023 · DA

General Clinical Research Center

$1,956,242
David A Kessler · University Of California, San Francisco · M01 · FY2006 · RR

Department of Veterans Affairs (VA) Cooperative Studies Program (CSP)

$1,955,928
National Institute On Drug Abuse · Y01 · FY2022 · DA

GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION

$1,955,140
University Of Utah · P01 · FY2002 · HL

Molecular and Cellular Pathogenesis in Alcoholism

$1,953,000
Fulton T Crews · Univ Of North Carolina Chapel Hill · P60 · FY2006 · AA

7/24 Healthy Brain and Child Development National Consortium

$1,952,554
Heather E Volk · Johns Hopkins University · U01 · FY2025 · DA

Non-Invasive Vagal Nerve Stimulation in Patients with Opioid Use Disorders

$1,952,098
James Douglas Bremner · Emory University · UH3 · FY2023 · DA

Drug development of clavulanic acid, a GLT-1 activator: proof of concept for cocaine use disorder

$1,951,956
Mary F. Morrison · Temple Univ Of The Commonwealth · U01 · FY2022 · DA

Activity-dependent Synaptic and Circuit Plasticity

$1,951,474
Robert C Malenka · Stanford University · P50 · FY2017 · MH

Methodology and Advanced Analytics Resource Center 2.0

$1,950,978
John Schneider · University Of Chicago · UM1 · FY2024 · DA

CENTER ON TOBACCO USE SUSCEPTIBILITY AND INTERVENTION

$1,950,156
University Of California Irvine · P50 · FY2000 · DA

Monitoring the Future: A Cohort-Sequential Panel Study of Drug Use, Ages 19-55

$1,949,961
Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2015 · DA

Procurement and Characterization of Postmortem Brain Tissue

$1,949,906
Joel Kleinman · National Institute Of Mental Health · Z01 · FY2007 · MH

Neurocomputational mechanisms of learning and decision-making and their disruption in addiction

$1,949,768
Thorsten Kahnt · National Institute On Drug Abuse · ZIA · FY2025 · DA

ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah

$1,949,666
Torri D Metz · University Of Utah · U54 · FY2023 · HD

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Humans

$1,948,128
George R Uhl · National Institute On Drug Abuse · Z01 · FY2008 · DA

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$1,947,848
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

The Neurobiology of Social Decision-Making

$1,947,704
Ralph Adolphs · California Institute Of Technology · P50 · FY2012 · MH

SPRINT: Signature for Pain Recovery IN Teens

$1,947,476
Laura E Simons · Stanford University · R33 · FY2024 · NS

High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain

$1,947,043
Bryan L McLaughlin · Micro-Leads, Inc. · U44 · FY2023 · NS